CRT 2022: UZ Clear Finds 50% Patients with Angina Have Evidence of CAD | Dr Carlos Collet

Подробнее о видео

Watch the full video on Radcliffe Cardiology here:

In this video, Dr Carlos Collet (Cardiovascular Center OLV-Aalst, Aalst, BE) outlines the findings of the UZ Clear study, originally presented at CRT 2022. The UZ Clear study was designed to analyse the diagnostic performance of non-invasive cardiac stress tests to detect coronary artery disease (CAD)in patients. Dr Collet reveals that around half the patients presenting with chest pain had evidence of epicardial or microvascular CAD.

Discussion points:
1. Importance of this trial
2. Patient cohort and study design
3. Key findings
4. Further research required
5. Take-home messages

Recorded Remotely from Aalst, 2022.
Interviewer: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.